Men's Telehealth Service — Type D
Direct-to-consumer telehealth model targeting men's health concerns — sexual function, performance, body composition.
- Medical oversight3.3 / 5
- Transparency3.0 / 5
- Access clarity4.2 / 5
- Pricing clarity3.6 / 5
- Support clarity3.4 / 5
- Aftercare3.0 / 5
Strengths
- Low barrier to entry — useful for men who avoid traditional GPs
- Convenient consultation model
- Some operators do operate within approved indications
Concerns
- Marketing pressure often outweighs clinical caution
- Abbreviated medical assessments are common
- Aftercare and ongoing review is typically thin
- Compounded or research-context compounds sometimes pushed outside lawful scope
Editorial review
Men's telehealth services are highly visible in Australian advertising and operate primarily on volume. The strong versions are GP-led with genuine medical assessment; the weak versions are essentially marketing funnels that route patients through abbreviated questionnaires to a pre-determined prescription.
Peptide content varies widely. Some operate within approved indications (e.g. PT-141 for HSDD where registered). Others push compounded preparations or research-context compounds outside their lawful scope.
What to look for: AHPRA-registered prescribers named on the site, a real medical assessment (not a 60-second form), and clear separation between health content and commercial offers.
Compounds typically prescribed
- Bremelanotide / PT-141 (where approved)
- Sexual health adjacent compounds
- Some GLP-1 agonists
Typical eligibility
- Adult men with relevant health concerns
- Willing to complete the service's medical intake
FAQs
Comparing models? Browse the full clinic hub.
See all clinic profiles